Table 1.
Pathological features of COVID-19 lungs.
| COVID-19 feature | 2D Histology | 3D Histology |
|---|---|---|
| Apoptosis | (46) | |
| Diffuse alveolar damage | (27, 28, 30–39, 41–43, 45) | (20, 28) |
| Aberrant capillarization | (30) | (30) |
| Edema | (27, 29, 30, 32, 43, 47) | |
| Emphysema | (28) | |
| Hemorrhage | (27, 29, 42) | |
| Hyaline membrane | (27–29, 31, 41–43, 45) | (20, 28) |
| Interstitial leukocytes | (27–32, 35, 37, 40, 42, 43, 45, 46) | (20, 28) |
| Microthrombi | (27–44) | (20, 28, 30) |
| Neutrophil extracellular traps | (40, 44, 48) | |
| Septal thickening | (28, 46) | (28) |
| Viral infection-like changes | (27, 28, 30, 31, 45–47) | (20) |